Multiple sclerosis under the "MRI-croscope"
The major goal of our research is to understand how multiple sclerosis injures the brain and spinal cord, how to stop that injury, and how to promote repair. To do this, we use noninvasive or minimally invasive imaging methods, particularly magnetic resonance imaging (MRI). We perform long-term studies on time scales that are relevant for disease processes, examine radiological-pathological correlations in autopsy tissue and animal models, and elucidate the cellular and molecular pathways involved. We develop and perform experiments with new MRI techniques on state-of-the-art imaging equipment in the NIH Clinical Center and elsewhere on the NIH campus, and we collaborate closely with the NINDS Neuroimmunology Clinic as well as numerous other groups at and outside NIH.
PRINCIPAL INVESTIGATOR
Daniel S. Reich, M.D., Ph.D.
Dr. Daniel Reich is Senior Investigator at NIH/NINDS, where he directs the Translational Neuroradiology Section and leads clinical studies focusing on multiple sclerosis (MS). He studied math and physics at Yale and earned his MD from Cornell and his PhD in neurophysiology from The Rockefeller University. His training includes a fellowship in diagnostic neuroradiology and residencies in radiology and neurology at Johns Hopkins Hospital. He is a founder of the North American Imaging in MS Cooperative (NAIMS) and serves on the Board of Directors of the Americas Committee for Treatment and Research in MS (ACTRIMS). He is an elected member of the American Society of Clinical Investigation and the Association of American Physicians, the 2015 winner of the American Neurological Association’s Derek Denny-Brown Young Neurological Scholar Award, the 2016 winner of the National MS Society’s Barancik Award for Innovation in MS Research, and a 2017 winner of the NIH Graduate Partnership Programs Outstanding Mentor Award.